Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing mechanical valves with reduced anticoagulation.

Mark S Slaughter1, Eias Jweied

  • 1Advocate Christ Medical Center, 4440 West 95th Street, Oak Lawn, IL 60453, USA. mscabg@aol.com

Expert Review of Cardiovascular Therapy
|November 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Makes a Great Manuscript?

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Transcatheter or Surgical Aortic-Valve Replacement at 7 Years.

The New England journal of medicine·2026
Same author

Integrative Clinical-Molecular Modeling Identifies <i>LRRN4CL</i> as a Determinant of Structural and Functional Myocardial Improvement.

bioRxiv : the preprint server for biology·2026
Same author

Retrograde perfusion of the dorsalis pedis artery versus traditional distal perfusion catheter use in venoarterial extracorporeal membrane oxygenation.

JTCVS open·2026
Same author

Modifying a traditional femoral venoarterial extracorporeal membrane oxygenation cannulation strategy and circuit to improve distal limb hemodynamics.

JTCVS open·2026
Same author

Local amiodarone delivery via an extracellular collagen matrix patch to reduce new-onset postoperative atrial fibrillation.

JTCVS open·2026
Same journal

Prosthetic valve thrombosis: contemporary concepts in diagnosis and management.

Expert review of cardiovascular therapy·2026
Same journal

Life's essential 8 and its role in cardiovascular health: evolution, evidence, and future directions.

Expert review of cardiovascular therapy·2026
Same journal

Efficacy and safety of clopidogrel and aspirin initiated within 72 hours after mild ischemic stroke or high-risk TIA by sex: a prespecified subgroup analysis of the INSPIRES trial.

Expert review of cardiovascular therapy·2026
Same journal

Approaches to transcatheter aortic valve replacement failure: is more focus on prevention required?

Expert review of cardiovascular therapy·2026
Same journal

Vericiguat for heart failure with reduced ejection fraction: a perspective from approval to real-world clinical treatment.

Expert review of cardiovascular therapy·2026
Same journal

Early autonomic neuropathy in prediabetes: an overlooked driver of cardiometabolic risk.

Expert review of cardiovascular therapy·2026
See all related articles

The choice between mechanical and bioprosthetic heart valves balances longevity against anticoagulation risks. Advances in mechanical valves and patient self-management may shift current trends favoring bioprosthetic options.

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science
  • Pharmacology

Background:

  • Heart valve replacement choices have evolved over 40 years.
  • The selection hinges on balancing prosthesis durability with anticoagulation therapy needs.
  • Bioprosthetic valves offer freedom from continuous anticoagulation but have limited lifespans, while mechanical valves necessitate it, posing bleeding or thromboembolism risks.

Purpose of the Study:

  • To review the historical trends and current considerations in heart valve replacement selection.
  • To discuss the trade-offs between bioprosthetic and mechanical valve therapies.
  • To highlight emerging research and patient self-management strategies impacting valve choice.

Main Methods:

  • Literature review of heart valve replacement strategies.

Related Experiment Videos

  • Analysis of prosthesis longevity versus anticoagulation therapy requirements.
  • Examination of advancements in mechanical valve technology and anticoagulation management.

    • Main Results:

    • Bioprosthetic valves are currently favored due to reduced anticoagulation needs.
    • Mechanical valves require anticoagulation therapy, carrying risks of bleeding and thromboembolism.
    • Progress is being made in developing less thrombotic mechanical valves.
    • Patient self-management of anticoagulation therapy improves efficacy and reduces dosage.

    Conclusions:

    • The trend towards bioprosthetic valves may reverse with improved mechanical valve technology and anticoagulation management.
    • Optimized anticoagulation strategies, including patient self-management, are crucial for mechanical valve therapy.
    • Future heart valve selection will likely depend on the evolving balance between prosthesis performance and patient safety.